Testaplex E Axio Labs 200 mg/ml

$18.00

Substance: Testosterone EnanthatePackage: vial (200 mg/ml)

Description

TESTAPLEX E 200 AXIOLABS REVIEW

TestaPlex E 200 injection, for intramuscular injection, contains Testosterone Enanthate which is insoluble in water, very soluble in ether and soluble in vegetable oils.

Androgens are derivatives of cyclopentano-perhydrophenanthrene. Endogenous androgens are C-19 steroids with a side chain at C-17, and with two angular methyl groups. Testosterone is the primary endogenous androgen. In it active form, TestaPlex E 200 have a 17-beta-hydroxy group. Esterification of the 17-beta-hydroxy group produces compounds (Testosterone Enanthate and Testosterone Propionate) which have a longer duration of action and are hydrolyzed in vivo to free Testosterone.

TESTAPLEX E 200 SIDE EFFECTS

TestaPlex E 200 contains endogenous androgens, which are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include the growth and maturation of prostate, seminal vesicles, penis and scrotum; the development of male hair distribution, such as beard, pubic, chest and axillary hair; laryngeal enlargement, vocal chord thickening, alterations in body musculature, and fat distribution. TestaPlex E 200 cause retention of nitrogen, sodium, potassium, phosphorous, and decreased urinary excretion of calcium. Androgens have been reported to increase protein anabolism and decrease protein catabolism. Nitrogen balance is improved only when there is sufficient intake of calories and protein.

Androgens are responsible for the growth spurt of adolescence and for the eventual termination of linear growth which is brought about by fusion of the epiphyseal growth centers. In children, exogenous androgens accelerate linear growth rates, but may cause a disproportionate advancement in bone maturation. Use TestaPlex E 200 over long periods may result in fusion of the epiphyseal growth center and termination of growth process.

Androgens have been reported to stimulate the production of red blood cells by enhancing the production of erythropoietic stimulating factor.

During exogenous administration of androgens, endogenous Testosterone release is inhibited through feedback inhibition of pituitary luteinizing hormone (LH). At large doses of Testaplex E 200, spermatogenesis may also be suppressed through feedback inhibition of pituitary follicle stimulating hormone (FSH).